• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒诊断:从分子到组学。

COVID Diagnostics: From Molecules to Omics.

机构信息

Department of Chemical Pathology. National Health Laboratory Services and University of Witwatersrand, Johannesburg, South Africa.

Wits Diagnostic and Innovation Hub, University of Witwatersrand, Johannesburg, South Africa.

出版信息

Adv Exp Med Biol. 2023;1412:141-158. doi: 10.1007/978-3-031-28012-2_7.

DOI:10.1007/978-3-031-28012-2_7
PMID:37378765
Abstract

The identification and genetic sequencing of a novel coronavirus was key to the diagnosis and management of the global pandemic. An understanding of the SARS-CoV-2 structure and mechanism of injury is vital to explaining the disease course and the pathophysiology of the signs and symptoms observed. This particularly as the presentation, disease course, and severity are noted to be highly variable. The role of the spike protein and angiotensin-converting enzyme 2 (ACE-2) receptor in immune response and viral entry provides great insight into current and future diagnostics and therapeutics. This article reviews the traditional diagnostic methods, which include molecular testing methods, antigen testing, and antibody testing. The gold standard for diagnosis of COVID-19 is reverse transcriptase polymerase chain reaction (RT-PCR). There have been multiple improvements to these principles to help optimize the sensitivity, specificity, and user friendliness of the method. In addition, advancements in gene sequencing and identification have been integral to identifying variants and managing outbreaks. Serological and immunological testing have made significant contributions to the management of the COVID-19 pandemic, each with its unique benefits and limitations. A growing role of the laboratory is in triaging patients to determine which patients will most benefit from hospitalization and specialized care. This is imperative for rationalizing resources during outbreaks. As we learn to live with the pandemic, novel testing methods include the use of multiomic technologies and the greater utility of point of care.

摘要

新型冠状病毒的鉴定和基因测序是诊断和管理全球大流行的关键。了解 SARS-CoV-2 的结构和损伤机制对于解释疾病过程和观察到的症状的病理生理学至关重要。特别是因为其表现、病程和严重程度都被认为是高度可变的。刺突蛋白和血管紧张素转换酶 2(ACE-2)受体在免疫反应和病毒进入中的作用为当前和未来的诊断和治疗提供了重要的见解。本文回顾了传统的诊断方法,包括分子检测方法、抗原检测和抗体检测。COVID-19 的诊断金标准是逆转录聚合酶链反应(RT-PCR)。为了帮助提高方法的灵敏度、特异性和易用性,已经对这些原则进行了多次改进。此外,基因测序和鉴定的进步对于识别变体和管理疫情至关重要。血清学和免疫学检测对 COVID-19 大流行的管理做出了重大贡献,每种方法都有其独特的优势和局限性。实验室的作用越来越大,在于对患者进行分诊,以确定哪些患者最需要住院和专业护理。这对于在疫情期间合理分配资源至关重要。随着我们学会与大流行共存,新型检测方法包括使用多组学技术和更多地使用即时护理。

相似文献

1
COVID Diagnostics: From Molecules to Omics.新冠病毒诊断:从分子到组学。
Adv Exp Med Biol. 2023;1412:141-158. doi: 10.1007/978-3-031-28012-2_7.
2
[SARS-CoV-2 and Microbiological Diagnostic Dynamics in COVID-19 Pandemic].[严重急性呼吸综合征冠状病毒2与2019冠状病毒病大流行中的微生物诊断动态]
Mikrobiyol Bul. 2020 Jul;54(3):497-509. doi: 10.5578/mb.69839.
3
A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2).一种新型的 SARS-CoV-2 刺突蛋白 1 抗原的快速检测方法,利用人血管紧张素转换酶 2(ACE2)。
Biosens Bioelectron. 2021 Jan 1;171:112715. doi: 10.1016/j.bios.2020.112715. Epub 2020 Oct 15.
4
COVID-19 Clinical Diagnostics and Testing Technology.新型冠状病毒肺炎临床诊断与检测技术
Pharmacotherapy. 2020 Aug;40(8):857-868. doi: 10.1002/phar.2439.
5
Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.评价两种 SARS-CoV-2 快速 IgM-IgG 联合抗体检测试剂盒在指尖毛细血管全血样本中的性能。
PLoS One. 2020 Sep 17;15(9):e0237694. doi: 10.1371/journal.pone.0237694. eCollection 2020.
6
Combined Diagnosis of SARS-CoV-2: Rapid Antigen Detection as an Adjunct to Nucleic Acid Detection.SARS-CoV-2 联合诊断:快速抗原检测作为核酸检测的辅助手段。
Lab Med. 2023 Mar 7;54(2):e37-e43. doi: 10.1093/labmed/lmac089.
7
The diagnostic methods in the COVID-19 pandemic, today and in the future.新冠疫情时期及未来的诊断方法。
Expert Rev Mol Diagn. 2020 Sep;20(9):985-993. doi: 10.1080/14737159.2020.1816171. Epub 2020 Sep 16.
8
Diagnostic Performance Assessment of Saliva RT-PCR and Nasopharyngeal Antigen for the Detection of SARS-CoV-2 in Peru.秘鲁唾液 RT-PCR 和鼻咽拭子抗原检测 SARS-CoV-2 的诊断性能评估。
Microbiol Spectr. 2022 Aug 31;10(4):e0086122. doi: 10.1128/spectrum.00861-22. Epub 2022 Jul 18.
9
Serological antibody testing in the COVID-19 pandemic: their molecular basis and applications.新型冠状病毒肺炎大流行中的血清学抗体检测:其分子基础与应用。
Biochem Soc Trans. 2020 Dec 18;48(6):2851-2863. doi: 10.1042/BST20200744.
10
Current Status of Diagnostic Testing for SARS-CoV-2 Infection and Future Developments: A Review.SARS-CoV-2 感染诊断检测的现状及未来发展:综述
Med Sci Monit. 2020 Dec 17;26:e928552. doi: 10.12659/MSM.928552.

引用本文的文献

1
Molecular Mechanisms, Diagnoses, and Treatments of Respiratory Diseases.呼吸系统疾病的分子机制、诊断与治疗
Biomedicines. 2024 Dec 24;13(1):4. doi: 10.3390/biomedicines13010004.

本文引用的文献

1
Rapid Quantum Magnetic IL-6 Point-of-Care Assay in Patients Hospitalized with COVID-19.针对新冠肺炎住院患者的快速量子磁白细胞介素-6即时检测
Diagnostics (Basel). 2022 May 7;12(5):1164. doi: 10.3390/diagnostics12051164.
2
Role of Polypeptide Inflammatory Biomarkers in the Diagnosis and Monitoring of COVID-19.多肽炎症生物标志物在新型冠状病毒肺炎诊断和监测中的作用
Int J Pept Res Ther. 2022;28(2):59. doi: 10.1007/s10989-022-10366-5. Epub 2022 Jan 24.
3
Diagnostics for COVID-19: moving from pandemic response to control.COVID-19 诊断:从大流行应对转向控制。
Lancet. 2022 Feb 19;399(10326):757-768. doi: 10.1016/S0140-6736(21)02346-1. Epub 2021 Dec 20.
4
COVID-19 Diagnosis: Current and Future Techniques.新型冠状病毒肺炎诊断:当前和未来技术。
Int J Biol Macromol. 2021 Dec 15;193(Pt B):1835-1844. doi: 10.1016/j.ijbiomac.2021.11.016. Epub 2021 Nov 12.
5
COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.大规模单细胞转录组图谱揭示的新冠病毒免疫特征
Cell. 2021 Nov 11;184(23):5838. doi: 10.1016/j.cell.2021.10.023.
6
Distinct Metabolic Profile Associated with a Fatal Outcome in COVID-19 Patients during the Early Epidemic in Italy.在意大利新冠疫情早期,与 COVID-19 患者死亡结局相关的独特代谢特征。
Microbiol Spectr. 2021 Oct 31;9(2):e0054921. doi: 10.1128/Spectrum.00549-21. Epub 2021 Sep 1.
7
Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients.COVID-19 相关死亡风险因素:42 项研究和 423117 例患者的系统评价和荟萃分析。
BMC Infect Dis. 2021 Aug 21;21(1):855. doi: 10.1186/s12879-021-06536-3.
8
Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study.南非高 HIV 和结核病流行地区 COVID-19 相关住院死亡率的危险因素:一项队列研究。
Lancet HIV. 2021 Sep;8(9):e554-e567. doi: 10.1016/S2352-3018(21)00151-X. Epub 2021 Aug 4.
9
How to interpret and use COVID-19 serology and immunology tests.如何解读和使用 COVID-19 血清学和免疫学检测
Clin Microbiol Infect. 2021 Jul;27(7):981-986. doi: 10.1016/j.cmi.2021.05.001. Epub 2021 May 8.
10
COVID-19 testing and diagnosis: A comparison of current approaches.COVID-19 检测与诊断:现有方法比较。
Malays J Pathol. 2021 Apr;43(1):3-8.